Versigent (NYSE:VGNT) Coverage Initiated at UBS Group

UBS Group started coverage on shares of Versigent (NYSE:VGNT) in a research report issued on Tuesday, Marketbeat reports. The brokerage set a “buy” rating and a $43.00 price target on the stock. UBS Group’s price objective suggests a potential upside of 25.32% from the stock’s previous close.

Several other research firms also recently weighed in on VGNT. TD Cowen started coverage on shares of Versigent in a research report on Tuesday. They issued a “buy” rating and a $47.00 target price on the stock. Royal Bank Of Canada initiated coverage on shares of Versigent in a research note on Tuesday, March 31st. They issued a “sector perform” rating and a $28.00 price objective for the company. Fox Advisors upgraded shares of Versigent to a “strong-buy” rating in a research report on Tuesday, April 7th. Finally, Wells Fargo & Company began coverage on shares of Versigent in a research note on Monday, April 6th. They set an “overweight” rating and a $35.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $38.25.

Versigent Trading Up 4.2%

NYSE VGNT opened at $34.31 on Tuesday. Versigent has a 1 year low of $26.34 and a 1 year high of $34.99.